Actinium Pharmaceuticals, Inc.
- Last sale
- Nov 2, 2026 · -4.36%
- Market cap
- $44.80M
- 31.44M shares
- Filings
- 512
Q3 2026+11.1% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−34.2% FY25 yoy
- $44.80M
- —
- 497.8×
- 1.8×
- -55.09%
- —
FY2025 figures · derived
Price
Nov 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $90,000 | reported | |
| FY 2023 | 2023-12-31 | $81,000 | reported | |
| FY 2022 | 2022-12-31 | $1,030,000 | reported | |
| FY 2021 | 2021-12-31 | $1,144,000 | reported | |
| FY 2011 | 2011-12-31 | $0 | reported | |
| FY 2010 | 2010-12-31 | $0 | reported |
Pharmaceutical preparations
Actinium Pharmaceuticals, Inc. is the 243rd largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
SERSerina Therapeutics, Inc.$130.0K132.1%14,755.4%$37.7MBFRGBullFrog AI Holdings, Inc.$116.7K—5,569.6%$10.5MIBIOiBio, Inc.$100.0K75.0%33,044.0%$53.9M
ATNMActinium Pharmaceuticals, Inc. (this company)$90.0K—37,652.2%$44.8M
SILOSilo Pharma, Inc.$72.1K0.0%5,863.5%$3.6MINOInovio Pharmaceuticals, Inc.$65.3K70.0%130,000.0%$274.4MCNTBConnect Biopharma Holdings Ltd$64.0K99.8%86,687.5%$42.0MAVTXAvalo Therapeutics, Inc.$59.0K86.6%132,642.4%$444.4MHCWBHCW Biologics Inc.$54.2K97.9%14,677.1%$1.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR